Abstract

Rheumatic Disease Biomarkers: Unlocking the Future of Diagnosis and Treatment

Author(s): Ashima Sen Roy*

Rheumatic diseases encompass a broad range of conditions characterized by inflammation, pain, and degeneration of the joints, muscles, and connective tissues. These diseases, which include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and ankylosing spondylitis (AS), are often chronic and debilitating, requiring early diagnosis and effective treatment to prevent long-term damage. In recent years, biomarkers have emerged as powerful tools in the diagnosis, prognosis, and management of rheumatic diseases. These biomarkers, which are measurable indicators of biological processes, can provide critical insights into disease mechanisms, predict disease progression, and guide personalized treatment strategies.